The landscape of dementia diagnosis has progressed radically with the arrival of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based assessments that could detect Alzheimer's pathology many years right before signs or symptoms emerge. Though these technological improvements signify extraordinary progress in being familiar with neurodegenerative condit... https://neuropsychological-testin95112.ssnblog.com/36927284/the-enduring-price-of-cognitive-evaluation-for-older-older-people